"instanceType","name","label","id","description","text","uuid:ID"
"Objective","OBJ1","","Objective_1","Main objective","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","e658a81e-c681-4daf-828d-cf313a350c50"
"Objective","OBJ2","","Objective_2","Safety","To document the safety profile of the xanomeline TTS.","fcb953c3-4172-4273-a6df-a8c38dd88955"
"Objective","OBJ3","","Objective_3","Behaviour","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","8c4e786a-cb83-42e4-acc9-5415a155c1ff"
